Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

NCT04863950 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Lomustine
DRUG: Imipramine Hydrochloride

Sponsor

The University of Texas Health Science Center at San Antonio